MyFinsight
Home
Blog
About
Contact
Download
Download image
Prepaid expenses and
other current assets
$1,067,409
Cash and cash
equivalents
$12,554,289
Other long-term
assets
$29,780
Operating lease
right-of-use asset
$380,841
Property, plant &
equipment, net
$595,271
Total current assets
$13,621,698
Total assets
$14,627,590
Total liabilities and
stockholders' equity
$14,627,590
Total stockholders'
equity
$7,997,306
Series d preferred
stock, 111.11 shares...
$1,382,023
Total liabilities
$5,248,261
Accumulated deficit
-$263,838,280
Additional paid-in capital
$271,314,776
Lease liability, net
of current portion
$335,895
Total current
liabilities
$4,912,366
Common stock, 0.00001
par value...
$32
Series e-2 preferred
stock, 1,225 shares...
$520,778
Lease liability,
current
$96,034
Warrant liability
$801,650
Accounts payable and
accrued liabilities
$4,014,682
Back
Back
Balance Sheet
source: myfinsight.com
Cellectar Biosciences, Inc. (CLRB)
Cellectar Biosciences, Inc. (CLRB)